Bank of Montreal
DNLI icon

Bank of Montreal’s Denali Therapeutics DNLI Stock Holding History

Bank of Montreal’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-42,259
Closed -$1.24M – 3599
2024
Q3 		$1.24M Buy
+42,259
New +$1.05M ﹤0.01% 1922
2024
Q2 		– Sell
-42,288
Closed -$881K – 3933
2024
Q1 		$881K Buy
+42,288
New +$795K ﹤0.01% 2075
2023
Q3 		– Sell
-8,391
Closed -$262K – 3893
2023
Q2 		$262K Buy
+8,391
New +$236K ﹤0.01% 3054
2021
Q2 		– Sell
-1,885
Closed -$100K – 3985
2021
Q1 		$100K Sell
1,885
-7,951
-81% -$532K ﹤0.01% 3382
2020
Q4 		$754K Buy
9,836
+6,850
+229% +$414K ﹤0.01% 2449
2020
Q3 		$111K Sell
2,986
-2,045
-41% -$61.6K ﹤0.01% 3021
2020
Q2 		$135K Buy
5,031
+4,555
+957% +$107K ﹤0.01% 2931
2020
Q1 		$8K Sell
476
-5,547
-92% -$116K ﹤0.01% 3549
2019
Q4 		$105K Buy
6,023
+1,221
+25% +$20.3K ﹤0.01% 3469
2019
Q3 		$73K Buy
4,802
+812
+20% +$15.5K ﹤0.01% 3448
2019
Q2 		$83K Buy
+3,990
New +$89.4K ﹤0.01% 3455
2019
Q1 		– Sell
-648
Closed -$13K – 4410
2018
Q4 		$13K Buy
648
+333
+106% +$6.04K ﹤0.01% 3791
2018
Q3 		$7K Buy
315
+195
+163% +$3.23K ﹤0.01% 4025
2018
Q2 		$2K Buy
+120
New +$2.26K ﹤0.01% 4339

Other funds holding DNLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Bank of Montreal's DNLI Position: Q4 2024 in Review

Bank of Montreal sold out of Denali Therapeutics (DNLI) in Q4 2024, closing a stake of 42,259 shares — an estimated $1.24M sold.

Bank of Montreal first reported a position in DNLI in Q2 2018 and held it in 14 quarters. The position peaked at $1.24M in Q3 2024. 223 funds tracked by Wall St. Rank hold DNLI as of Q4 2024.

  • Bank of Montreal reported no remaining Denali Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 42,259 Denali Therapeutics shares in Q4 2024, an estimated $1.24M.
  • Bank of Montreal first reported a position in Denali Therapeutics in Q2 2018 and held it in 14 quarters.
  • Bank of Montreal's Denali Therapeutics position peaked at $1.24M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held Denali Therapeutics as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.